Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRTX is expected to report earnings to rise 1.48% to $4.80 per share on November 09

Vertex Pharmaceuticals VRTX Stock Earnings Reports

Q3'26

Est.

$4.80

Q2'26

Beat

by $0.01

Q1'26

Beat

by $0.14

Q4'25

Missed

by $0.05

Q3'25

Beat

by $0.23

The last earnings report on August 03 showed earnings per share of $4.73, beating the estimate of $4.72. With 431.43K shares outstanding, the current market capitalization sits at 130.64B.

View a ticker or compare two or three

VRTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for VRTX